AUTHOR=Xu Wenchao , Sun Taotao , Wang Jiaxin , Li Hao , Chen Bingliang , Zhou Yingjian , Wang Tao , Wang Shaogang , Liu Jihong , Jiang Hongyang 

TITLE=LMO3 downregulation in PCa: A prospective biomarker associated with immune infiltration

JOURNAL=Frontiers in Genetics

VOLUME=Volume 13 - 2022

YEAR=2022

URL=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.945151

DOI=10.3389/fgene.2022.945151

ISSN=1664-8021

ABSTRACT=Prostate cancer is the third leading cause of new cancer cases and the second common tumor type in men globally. LMO3 has been stated to play a vital part in some cancers; however, the prognostic value of LMO3 in PCa remains vague. Here, we utilized various web databases to detailly elucidate the prognostic value and molecular functions of LMO3 in PCa. LMO3 expression was significantly decreased in PCa. Low LMO3 expression was associated with gender, age, TNM grade and predicted a poor prognosis in PCa patients. Functional enrichment analysis suggested that LMO3 is engaged in the extracellular matrix and immune response. Moreover, LMO3 was positively correlated with the immune infiltration levels and numerous immune markers. LMO3 may function as a prospective biomarker of immune infiltration in PCa.